Allergan plc. (AGN) Receives ‘Analyst’ Rating

Allergan plc. (AGN) : 9 brokerage houses believe that Allergan plc. (AGN) is a Strong Buy at current levels. 3 Analyst considers the fundamentals to be worthy of a Buy recommendation. 3 analysts believe that the current prices are in a balance with the stocks fundamentals, hence they propose Hold on Allergan plc. (AGN). Zacks Investment Research suggests a Hold with a rank of 3.The median of all the 15 Wall Street Analysts endorse the stock as a Buy with a rating of 1.57.

Allergan plc. (AGN) : Average target price received by Allergan plc. (AGN) is $295.73 with an expected standard deviation of $42.1. The most aggressive target on the stock is $400, whereas the most downbeat target is $227. 11 financial analysts are currently covering the stock.


Also, In the latest statement by the brokerage house, Mizuho Securities upgrades its outlook on Allergan plc. (NYSE:AGN). The current rating of the shares is Buy, according to the research report released by the firm. Previously, the company had a rating of Neutral. The rating by the firm was issued on August 19, 2016.

Allergan plc. (NYSE:AGN): After opening at $244.08, the stock dipped to an intraday low of $244.01 on Thursday. However, the bulls stepped in to buy at lower levels and pushed the stock higher. The stock touched an intraday high of $248.49 and the buying power remained strong till the end. The stock closed at $246.44 for the day, a gain of 0.67% for the day session. The total traded volume was 3,705,193. The stocks close on the previous trading day was $244.81.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.